Vanguard Portfolio Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$384M Sell
761,024
-20,707
-3% -$10.9M 0.02% 799
2026
Q2
$420M Sell
781,731
-59,414
-7% -$30.4M 0.02% 793
2026
Q1
$440M Buy
+841,145
New +$402M 0.02% 717

Other funds holding MDGL

Vanguard Portfolio Management's MDGL Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.6% in Q3 2026, selling an estimated $10.9M and leaving 761,024 shares worth $384M. The position accounts for 0.02% of the portfolio, ranked #799.

Vanguard Portfolio Management first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. The position peaked at $440M in Q1 2026. 429 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Vanguard Portfolio Management held 761,024 shares of Madrigal Pharmaceuticals worth $384M as of Q3 2026.
  • Vanguard Portfolio Management sold 20,707 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $10.9M.
  • Madrigal Pharmaceuticals made up 0.02% of Vanguard Portfolio Management's portfolio in Q3 2026, its #799 holding.
  • Vanguard Portfolio Management first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Madrigal Pharmaceuticals position peaked at $440M in Q1 2026.
  • 429 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.